Ambu A/S/€AMBUB
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Ambu A/S
Ambu A/S is a Danish company operating in the medical device industry, primarily involved in the development, manufacturing, and marketing of innovative healthcare solutions. The company's key products include single-use endoscopes, anesthesia devices, and patient monitoring and diagnostic solutions. Ambu was founded in 1937 and is headquartered in Ballerup, Denmark. It is known for its focus on single-use devices, which help reduce the risk of cross-contamination and improve efficiency in hospitals and clinics worldwide. The company's strategic positioning emphasizes innovation in medical technology and a strong commitment to addressing healthcare challenges globally.
Ticker
€AMBUB
Sector
Primary listing
CSE
Employees
5,000
Headquarters
Ballerup, Denmark
Website
Ambu A/S Metrics
BasicAdvanced
€3.3B
66.66
€0.19
1.28
€0.05
0.41%
Price and volume
Market cap
€3.3B
Beta
1.28
52-week high
€20.72
52-week low
€12.10
Average daily volume
561K
Dividend rate
€0.05
Financial strength
Current ratio
2.882
Quick ratio
1.575
Long term debt to equity
8.083
Total debt to equity
9.368
Dividend payout ratio (TTM)
27.57%
Interest coverage (TTM)
21.41%
Profitability
EBITDA (TTM)
127.817
Gross margin (TTM)
60.27%
Net profit margin (TTM)
6.34%
Operating margin (TTM)
13.58%
Effective tax rate (TTM)
15.53%
Revenue per employee (TTM)
€156,750
Management effectiveness
Return on assets (TTM)
6.84%
Return on equity (TTM)
6.42%
Valuation
Price to earnings (TTM)
66.661
Price to revenue (TTM)
4.218
Price to book
4.12
Price to tangible book (TTM)
9.2
Price to free cash flow (TTM)
60.024
Free cash flow yield (TTM)
1.67%
Free cash flow per share (TTM)
0.206
Dividend yield (TTM)
0.41%
Forward dividend yield
0.41%
Growth
Revenue change (TTM)
14.96%
Earnings per share change (TTM)
1.94%
3-year revenue growth (CAGR)
12.00%
10-year revenue growth (CAGR)
13.06%
3-year earnings per share growth (CAGR)
11.15%
10-year earnings per share growth (CAGR)
6.20%
3-year dividend per share growth (CAGR)
9.43%
10-year dividend per share growth (CAGR)
7.32%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Ambu A/S stock?
Ambu A/S (AMBUB) has a market cap of €3.3B as of August 18, 2025.
What is the P/E ratio for Ambu A/S stock?
The price to earnings (P/E) ratio for Ambu A/S (AMBUB) stock is 66.66 as of August 18, 2025.
Does Ambu A/S stock pay dividends?
Yes, the Ambu A/S (AMBUB) stock pays dividends to shareholders. As of August 18, 2025, the dividend rate is €0.05095 and the yield is 0.41%. Ambu A/S has a payout ratio of 27.57% on a trailing twelve-month basis.
When is the next Ambu A/S dividend payment date?
The next Ambu A/S (AMBUB) dividend payment date is unconfirmed.
What is the beta indicator for Ambu A/S?
Ambu A/S (AMBUB) has a beta rating of 1.28. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.